MEETINGS - Shanghai International Symposium on Liver Cancer & Hepatitis (China) March 2006:
This article was originally published in Clinica
Executive Summary
The Shanghai International Symposium on Liver Cancer & Hepatitis will take place during March 25-28 2006 at the Shanghai International Convention Centre, China. Lecture and workshop topics will include: screening, diagnosis and staging; diagnosis and prognosis of liver cancer; multimodality; Middle East workshop; liver transplantation, does East meet West?; surgical treatment for hepatocellular carcinoma (HCC); and genomics and proteomics workshop. For further details and to register, contact: Building 4, Room 303, Liver Cancer Institute and Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032. Tel: +86 21 6404 1990; fax: (8621) 6403 7181; email: [email protected] www.livercongress.org
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.